This topic contains a solution. Click here to go to the answer

Author Question: Which member of the sterile team provides exposure and hemostasis during a surgical procedure? a. ... (Read 122 times)

altibaby

  • Hero Member
  • *****
  • Posts: 562
Which member of the sterile team provides exposure and hemostasis during a surgical procedure?
 
  a. Anesthesia provider
  b. Circulating nurse
  c. Sales representative
  d. First assistant

Question 2

What are the surgeon's duties?
 
  a. Selection and performance of the surgery
  b. Pre-operative diagnosis
  c. Ethical surgical practice
  d. All of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

parker125

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

ANS: D
The surgical assistant provides exposure and hemostasis. This person can be a physician, RNFA, SA, PA, or a CST who is specially trained and certified as a first assistant.

Answer to Question 2

ANS: D
The surgeon's responsibilities include: pre-op diagnosis and care, selection and performance of the procedure, and post-op management of care.





 

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

Although puberty usually occurs in the early teenage years, the world's youngest parents were two Chinese children who had their first baby when they were 8 and 9 years of age.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Many of the drugs used by neuroscientists are derived from toxic plants and venomous animals (such as snakes, spiders, snails, and puffer fish).

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library